baber/WOPTO huggingface dataset:
Patent CA-3069103-A1 (CA)
Title: Post-foaming composition for protection against fire and/or heat
Inventor: LOVAS LASZLO
IPC: A62D1/02
Filed: 2017-07-06
Abstract: The invention relates to a post-foaming composition for protection against fire and/or heat, has a propellant ingredient of inert gas 0.5-6% by weight, alkali and/or alkaline earth metal silicate, as a fire-resistant component- to protect against fire and/or heat, less than 75% by weight; solvent medium, eg. water. The characteristic feature of the invention is that it has a booster gas or gas mixture component in addition to the inert gas, with atmospheric boiling point is under 20 ° C and vapor pressure at 20 ° C is between 1-5 bar (abs) added, in the amount of 0.1-10% by weight; and contains further fatty acids and/or fatty alcohols and/or their salts, and/or esters, and/or aldehydes, and/or amides thereof, as a carrier material, 0.5 to 20 % by weight, suitable for the capture of at least a portion of propellant gas or mixture of gases.
Patent CA-3071006-A1 (CA)
Inventor: ISAACSON SHAWN RAY
IPC: A61B5/145
Filed: 2018-08-03
Abstract: A needle (26) is provided that can be used for introducing or aspirating fluids to a patient or as an introducer needle for positioning and inserting a catheter (58), such as a peripheral IV catheter into a patient. The needle (26) can be an introducer needle that extends from the distal end of the catheter during insertion. The needle (26) has an insertion tip with a configuration to assist penetration into a vein (60) with a reduced incidence of injuring the inner surface of the vein or inadvertently passing through side wall of the vein.  The needle tip (46) can be formed with a curved distal end surface (54) where the pointed tip (46) is spaced radially inward relative to the outer surface (56) of the needle (26). In another embodiment the needle tip can have a reverse beveled surface (42, 44) having an axial length, angle, and curvature to assist in penetrating the vein with a reduced incidence of transfixing the vein.
Patent CA-3072394-A1 (CA)
Inventor: RENART-DEPONTIEU FLORENCE
IPC: A61P37/04
Filed: 2018-08-10
Abstract: Provided is a CD96-binding agent, wherein the agent is capable of stimulating activation and/or proliferation of T cells upon binding to CD96. Also provided are isolated nucleic acids and cells that produce the agent and uses thereof.
Patent CA-3072764-A1 (CA)
Title: Amantadine compositions, preparations thereof, and methods of use
Inventor: WENT GREGORY T
IPC: A61K31/13
Filed: 2018-08-23
Abstract: Provided herein are oral pharmaceutical compositions comprising amantadine, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient, and which have a low level of organic solvent. Provided are also methods of orally administrating a composition comprising amantadine, or a pharmaceutically acceptable salt thereof, to a subject, which has reduced gastrointestinal side effects or sleep disturbances. Further provided are extended release oral compositions comprising amantadine, or a pharmaceutically acceptable salt thereof, that are suitable for once daily administration.
Patent CA-3073264-A1 (CA)
Inventor: BOCHENKO WALTER JOHN
IPC: G01F15/14
Filed: 2016-08-25
Abstract: A system comprising a flow sensor contained within a flow sensor housing and a base that houses a controller that generates at least one operation modification signal, wherein the flow sensor is separable from and mountable onto the base.
Patent CA-3073630-A1 (CA)
Title: Dispositif de broyage pour broyer de la matiere
Inventor: PISCHON STEFAN
IPC: B02C25/00
Filed: 2018-08-20
Abstract: L'invention concerne un dispositif de broyage (1) pour broyer de la matière, en particulier des matériaux de valeur, du bois résiduel et des supports de données, comprenant un bâti de machine (2), au moins un rotor de broyage (3) monté de manière rotative sur le bâti de machine (2) et au moins un dispositif d'alimentation (4) au moyen duquel la matière à broyer peut être acheminée vers au moins un rotor de broyage (3). Au moins un dispositif de mesure (7, 8, 9) détecte en continu la position d'au moins un dispositif d'alimentation (4), un dispositif de commande et/ou de régulation (10) commande au moins et/ou régule le mouvement d'au moins un dispositif d'alimentation (4), et un dispositif de transmission de signaux (11) par lequel des signaux de mesure générés par l'au moins un dispositif de mesure (7, 8, 9) peuvent être transmis au dispositif de commande et/ou de régulation (10).
Patent CA-3073665-A1 (CA)
Inventor: ALMEIDA-PORADA MARIA GRACA N D
IPC: A61K48/00
Filed: 2018-08-23
Abstract: Disclosed herein are method of treating hemophilia A in a subject comprising injecting the subject with mesenchymal stromal/stem cells (MSC) modified to express high levels of Factor VIII protein. The MSC are injected into the subject prenatally. The modified MSC may also express high levels von Willebrand factor protein.
Patent CA-3075927-A1 (CA)
Title: Immunotherapy methods for patients whose tumors carry a high passenger gene mutation burden
Inventor: LIM WEI KEAT
IPC: C12Q1/6809
Filed: 2018-09-19
Abstract: Methods for selecting a cancer patient for immunotherapy comprise establishing a total passenger gene mutation burden from a tumor of a cancer patient, generating a background distribution for the mutational burden of the tumor, normalizing the total passenger gene mutation burden against the background distribution, and categorizing the cancer patient as an immunotherapy responder when the total passenger gene mutation burden is greater than the mean of the background distribution. When the cancer patient is an immunotherapy responder, the patient may be administered an immunotherapy regimen that comprises activation/inhibition of T cell receptors that promote T cell activation and/or prolong immune cytolytic activities.
Patent CA-3076614-A1 (CA)
Title: Traitement du prurit cholestatique
Inventor: BOUDES POL
IPC: A61P1/16
Filed: 2018-09-24
Abstract: La présente invention porte sur le traitement du prurit cholestatique par une thérapie utilisant le séladelpar ou un sel de celui-ci.
Patent CA-3077174-A1 (CA)
Title: A universal platform for preparing an inhibitory chimeric antigen receptor (icar)
Inventor: GROSS GIDEON
IPC: C12N15/10
Filed: 2018-09-28
Abstract: The present invention provides a method of identifying a target for preparing an inhibitory chimeric antigen receptor (iCAR) or a protective chimeric antigen receptor (pCAR) capable of preventing or attenuating undesired activation of an effector immune cell. Also provided are a list of iCAR targets, as well as vectors and transduced effector immune cells comprising the nucleic acid molecule and methods for treatment of cancer comprising administering the transduced effector immune cells are further provided.
Patent CA-3077820-A1 (CA)
Inventor: HORVATH JOSHUA
IPC: A61M5/168
Filed: 2013-01-04
Abstract: Un cathéter destiné à des applications médicales est décrit. Le cathéter comprend un tube ayant un trou de pointe à une extrémité et une partie dextrémité à lautre extrémité. Le fluide sort du cathéter au trou de pointe. Au moins un autre passage de fluide est disposé sur la paroi latérale du cathéter pour permettre un écoulement de sortie de médicament fluide en provenance du cathéter afin dassurer une administration appropriée du médicament à la zone cible désirée, en particulier lorsque louverture de pointe est occluse ou restreinte pour nimporte quelle raison.
Patent CA-3077840-A1 (CA)
Inventor: MALCOLM CHRISTIAN DAMIAN
IPC: B65D85/34
Filed: 2017-08-30
Abstract: Cases and containers for cooling produce may be cooperatively designed to provide cooling efficiencies in both passive ventilation and forced air cooling environments. Each container may include an element for helping form an opening or ventilation funnel within the center area of the cases, with a corresponding opening in the same arca of the case for allowing cooling fluid to pass therethrough. Further, each container may include an element for parsing or dividing incoming forced cooling fluid into both the lid and the base. In some versions of the containers, the air may be divided based at least in part on the design of the container, including the proportions of the containers lid to base structure. In this way the forced cooling fluid may be proportionately passed into the overall container to more efficiently cool the produce therein.
Patent CA-3078842-A1 (CA)
Inventor: LANGNES TOMMY
IPC: E21B47/10
Filed: 2018-10-10
Abstract: L'invention concerne un système de traitement de données acoustiques permettant d'identifier un événement, ledit système comprenant une unité de réception comportant un processeur et une mémoire, l'unité de réception étant configurée pour recevoir un signal d'un capteur disposé le long d'un trajectoire de capteur ou à travers une zone de capteur, et une application de traitement étant stockée dans la mémoire. L'application de traitement, lorsqu'elle est exécutée sur le processeur, configure le processeur pour : recevoir le signal du capteur, le signal comprenant une indication d'un signal acoustique reçu sur une ou plusieurs longueurs, le long de la trajectoire du capteur ou à travers une partie de la zone du capteur, et le signal indiquant le signal acoustique à travers un spectre de fréquence ; déterminer une pluralité de caractéristiques de domaine fréquentiel du signal à travers le spectre de fréquence ; et générer une sortie comprenant la pluralité de caractéristiques de domaine fréquentiel.
Patent CA-3079645-A1 (CA)
Title: Novel cytoprotective drugs
Inventor: BERNA PATRICK
IPC: A61P9/10
Filed: 2018-11-16
Abstract: The invention relates to compounds of the echinocandin family or a semi-synthetic derivative thereof or a salt thereof or an ester thereof, or an ester salt thereof, intended to be used as a cytoprotective drug, particularly as a drug for the prevention and/or protection and/or treatment of cell death and/or of degenerative pathological situations or processes which result in cell death, and even more particularly as a drug for the prevention and/or protection and/or treatment of cell death and/or degenerative pathological situations or processes which result in cell death, when they are associated with ischaemia-reperfusion.
Patent CA-3082415-A1 (CA)
Title: Compositions pour le traitement de fibres non fluorees et de textiles et leurs applications
Inventor: SARGENT RALPH R
IPC: D06M15/19
Filed: 2018-11-14
Abstract: Dans un aspect, la présente invention a trait à une composition pour traiter des fibres comprenant une phase continue aqueuse ou à base aqueuse acide et une phase hydrophobe comprenant un composant dendrimère et/ou un alkyle uréthane non dendrimère. La composition de traitement, par exemple, peut avoir un pH de 2,5 à 6,5. Dans certains modes de réalisation, de l'acide carboxylique est employé dans la composition de traitement pour fournir le caractère acide de la phase continue aqueuse ou à base aqueuse. De plus, la composition de traitement peut en outre comprendre au moins l'un parmi un composant résistant aux taches d'acide et un composant facilitant le lavage. Dans certains modes de réalisation, les fibres traitées avec les compositions décrites ici présentent un caractère ionique.
Patent CA-3082610-A1 (CA)
Inventor: BADER MICHAEL
IPC: A61K31/655
Filed: 2018-11-29
Abstract: The invention relates to a cosmetic method for modulating pigmentation in a subject, comprising administering a modulator of angiotensin-converting enzyme 2 (ACE2 modulator) to said subject. The invention encompasses methods in which the ACE2 modulator is an inhibitor of angiotensin- converting enzyme 2 (ACE2 inhibitor) and the ACE2 inhibitor is administered to increase pigmentation in said subject, in addition to methods where the ACE2 modulator is an activator of angiotensin-converting enzyme 2 (ACE2 activator) and the ACE2 activator is administered to decrease pigmentation in said subject. The invention further relates to the treatment of inflammatory skin disease by inhibition of angiotensin-converting enzyme 2. In some embodiments, the method relates to an inhibitor of angiotensin-converting enzyme 2 (ACE2 inhibitor) for use as a medicament in the treatment of inflammatory skin disease. The invention further relates to corresponding pharmaceutical and cosmetic compositions, preferably suited for topical administration of an ACE2 modulator.
Patent CA-3083369-A1 (CA)
Inventor: MCGRANE SCOTT
IPC: A23K20/142
Filed: 2018-12-20
Abstract: A pet food product comprising a fat component in an amount of from 2.0 wt% to 8.0 wt% by total weight of the pet food product, and a proteinaceous component in an amount of from 6.0 wt% to 14.0 wt% by total weight of the pet food product, wherein said proteinaceous component comprises polypeptides and free amino acids, wherein the ratio of the fat component to the proteinaceous component is from about 0.45:1.0 to about.0:1.0, and wherein the amount of free amino acids in the pet food product is at least 0.5 wt% by total weight of the pet food product.
Patent CA-3086038-A1 (CA)
Inventor: ANDERSSON STEFAN
IPC: B60R9/058
Filed: 2018-12-18
Abstract: Disclosed is a load carrier foot (2) for supporting a load bar (300) on a vehicle (1). The load carrier foot (2) comprises a locking mechanism (200) for releasably locking the load bar (300) on the load carrier foot (2). Furthermore, the locking mechanism (200) is configured to automatically return into a locking state in which the load bar (300) is locked on the load carrier foot (2).
Patent CA-3087186-A1 (CA)
Title: Combustion system and method for attenuation of combustion dynamics in a gas turbine engine
Inventor: DANIS ALLEN MICHAEL
IPC: F23R3/28
Filed: 2018-08-09
Abstract: The present disclosure is directed to a method of operating a combustion system to attenuate combustion dynamics. The method includes flowing, via a compressor section, an overall supply of air to the combustion system; flowing, via a fuel supply system, an overall flow of fuel to the combustion system; flowing, to a first fuel nozzle of the combustion system, a first supply of fuel defining a richer burning fuel-air mixture at the first fuel nozzle; flowing, to a second fuel nozzle of the combustion system, a second supply of fuel defining a leaner burning fuel-air mixture at the second fuel nozzle; and igniting the richer burning fuel-air mixture and the leaner burning fuel-air mixture to produce an overall fuel-air ratio at a combustion chamber of the combustion system.
Patent CA-3087826-A1 (CA)
Title: Derives d'oxadiazolopyridine a substitution benzyle, (pyridin-3-yl)methyle ou (pyridin-4-yl)methyle utilises en tant qu'inhibiteurs de la ghreline o-acyltransferase (goat)
Inventor: TRIESELMANN THOMAS
IPC: A61K31/444
Filed: 2019-01-28
Abstract: La présente invention concerne des composés de formule générale (I), dans laquelle les groupes R1 et R2 sont tels que définis dans la revendication 1, qui ont des propriétés pharmacologiques valorisables, en particulier, qui se lient à la ghréline O-acyltransférase (GOAT) et modulent son activité. Les composés selon l'invention sont appropriés pour le traitement et la prévention de maladies qui peuvent être influencées par ce récepteur, telles que des maladies métaboliques, en particulier l'obésité.
Patent CA-3089414-A1 (CA)
Inventor: LEI MAOYI
IPC: A61P29/00
Filed: 2019-01-29
Abstract: Disclosed are a crystal form of 1H-imidazo[4,5-b]pyridine-2(3H)-one compound (I) and a preparation method therefor and the use in preparing drugs for treating diseases associated with PDE4 receptors.
Patent CA-3090837-A1 (CA)
Title: Fonctionnement de partie de bande passante pendant une procedure de transfert intercellulaire
Inventor: KUANG QUAN
IPC: H04W36/00
Filed: 2019-01-14
Abstract: La présente invention concerne un terminal mobile permettant d'effectuer une procédure de transfert intercellulaire dans un système de communication mobile d'une source à une station de base cible. La station de base cible est configurée pour le terminal mobile avec au moins une première et une seconde partie de bande passante différente dans sa bande passante de cellule. Le terminal mobile comprend : un émetteur-récepteur qui, en fonctionnement, reçoit de la station de base source un message de commande de transfert intercellulaire comprenant des informations concernant les au moins première et seconde parties de bande passante configurées; et un processeur qui, en fonctionnement et lors de la réception du message de commande de transfert intercellulaire, active dans l'émetteur-récepteur au moins une partie sélectionnée parmi la première ou la seconde partie de bande passante configurée, et commande l'émetteur-récepteur afin d'effectuer, sur la ou les première ou seconde parties de bande passante configurée, la communication avec la station de base cible en tant que partie de la procédure de transfert intercellulaire.
Patent CA-3092103-A1 (CA)
Inventor: MOROSE GREGORY
IPC: C09K23/06
Filed: 2019-02-27
Abstract: A composition includes a first solvent selected from methyl acetate, dimethyl carbonate, acetone, or a combination thereof, a second solvent selected from thiophene, 1,3-dioxolane, thioacetic acid, or a combination thereof, and, optionally, a third solvent selected from dimethyl sulfoxide, methyl glyoxal, propylene carbonate, gamma butyrolactone, ethylene carbonate, 2-chloro-1-propanol, methanol, ethanol, ethylene glycol, propylene glycol, 1-propanol, 2-propanol, or a combination thereof. The respective amounts of each solvent are further described herein, and the total amounts of the first solvent, the second solvent, and the third solvent sum to at least 90 volume percent of the total volume of the composition. The composition can be particularly useful for removal of a coating from a surface. Accordingly, a method of removing a coating from a surface is also disclosed.
Patent CA-3093640-A1 (CA)
Title: Systems and methods for providing a web application to a computing device
Inventor: ZHENG JUN
IPC: G06F17/00
Filed: 2020-09-18
Abstract: System and methods are provided for providing a web application to a computing device. The method involves operating a system processor to:  receive, from the computing device, an application request including an application identifier associated with the web application; retrieve, from a data storage, an application template corresponding to the application identifier; build an application structure based at least on the retrieved application template and the application identifier; and transmit the application structure and a structure resolver to the computing device, the receipt of the structure resolver at the computing device triggers a device processor to resolve each dynamic content component defined within the application structure by:  determining, from the application structure, a layout definition of the dynamic content component, constructing the dynamic content component based on the layout definition, and retrieving a content data for the dynamic content component from the data storage.
Patent CA-3094411-A1 (CA)
Inventor: STIEGLER ACHIM
IPC: B65G35/08
Filed: 2019-03-20
Abstract: The invention relates to a container conveyor device (10) in a packaging machine having a container carrier (13) with a plurality of container receptacles (15). At least two rotary-driven linear conveyors (11, 28) are provided, and the container carrier (13) has at least one engagement part (14) which can be brought into engagement with the linear conveyors (11, 28). Two curved conveyors (20, 34) each have a curved guide track (21, 35) with which at least one projection of the container carrier (13) can be brought into engagement. A plurality of container carriers (13) can be transported along the upper linear conveyor (11) in a row with a mutual first spacing of less than 30 mm and at an average speed V0. The container carriers can be transported along the lower linear conveyor (28) with a mutual second spacing which is greater than the first spacing and at an average speed Vu, where Vu = 1.5 V0.
Patent CA-3096043-A1 (CA)
Inventor: EVANS RAAB ERICA
IPC: A61P35/04
Filed: 2019-04-03
Abstract: Disclosed herein is the treatment of a subject afflicted with a cancer having an activating RET alteration by administering an effective amount of a selective RET inhibitor, e.g., Compound 1 or pharmaceutically acceptable salts thereof, including, e.g., administering an amount of 300 mg to 400 mg of the selective RET inhibitor once daily.
Patent CA-3096626-A1 (CA)
Inventor: SINGLA VINEET
IPC: H04L12/58
Filed: 2020-10-16
Abstract: A communications server selectively allows communications based on indications of compatibility of the users who wish to communicate, as evidenced by mutual selection of the same elements of content sets that apply to each of the users.
Patent CA-3098031-A1 (CA)
Title: Inductive heating of air data probes
Inventor: BUENZ MARK
IPC: B64D15/12
Filed: 2020-11-02
Abstract: AB STRACT An air data probe includes a faceplate, a body connected to the faceplate, and a heating system comprising a coil, the coil being connected to the faceplate.  The coil generates an electromagnetic field that couples with the body to heat the body.   Date Recue/Date Received 2020-11-02
Patent CA-3099966-A1 (CA)
Title: Replaceable prism with flexible tab system for applanation tonometer, applanation tonometer containing same, and method of loading prism into applanation tonometer
Inventor: FALCK FRANCIS Y
IPC: A61B3/15
Filed: 2019-05-21
Abstract: An optical prism mounting system is described that includes a prism having a flexible insertion tab system. Also described, is a prism holder having an insertion channel, and a method of mounting the prism in a tonometer. The flexible insertion tab system includes a spring tab and a bendable tab; the spring tab is flexed as the prism moves along the channel; the flexible insertion tab system connects with the prism holder and snaps into a locked position at the end of the channel; and the prism and the prism holder can be separated after use by disengaging the flexible insertion tab system. An optical operating range of the optical prism is from about 0 ADC to about 600 ADC, and the maximum time for setting the tonometer is not more than about 150 seconds.
Patent CA-3101046-A1 (CA)
Inventor: ELLIOTT IAN G
IPC: C10M141/12
Filed: 2019-05-10
Abstract: Disclosed is a lubricating engine oil composition for a direct injected, boosted, spark ignited internal combustion engine comprising from about 25 to about 3000 ppm of metal from at least one manganese-containing compound, based on the total weight of the lubricating oil. The at least one manganese-containing compound has has the following formula: Also disclosed is a method for preventing or reducing low speed pre-ignition in an engine lubricated with said lubricating engine oil composition.
Patent CA-3104400-A1 (CA)
Title: Therapeutic device using far-infrared radiation
Inventor: WEY ALBERT CHIN-TANG
IPC: A61F7/00
Filed: 2020-12-30
Abstract: CA Application CPST Ref: 40221/00001 1 ABSTRACT 2 This invention relates to a therapeutic device for treating a human or animal body, 3 comprising an array of infrared-emitting elements disposed on or within a flexible substrate and 4 attached to the body part to be treated using an attachment means, said array comprising a first plurality of infrared-emitting ceramic elements having a specific spectral luminance covering at 6 least a part of the 3 ¨ 7 micrometer wavelength spectrum and having a peak wavelength between 7 3 and 7 micrometers, and a second plurality of infrared-emitting ceramic elements having a 8 .. specific spectral luminance covering at least a part of the 7 ¨ 14 micrometer wavelength spectrum 9 and having a peak wavelength between 7 and 14, that provides an effective means to healing the .. body. 11 CPST Doc: 325156.1 Date Recue/Date Received 2020-12-30